Prototyping and Evaluation

Prototyping and Evaluation Prototyping is at the heart of our business.

Since our foundation we have always had extensive workshop and prototyping facilities in the centre of our studios.

This enables us to explore, test and iterate concepts at increasing levels of resolution throughout a project and is a fundamental part of our product development and risk management processes.

The multi-billion selling SoloStar ® pen injector is one of the world’s best known drug delivery devices.

DCA partnered Sanofi throughout the development of SoloStar® , applying our rigorous evidencebased approach to all aspects of the design. The result is a device that delivers leading performance in almost every respect. With superior levels of safety and comfort, the pen is sophisticated, yet simple to use. Since its launch in 2007, SoloStar® has been adapted for use across a range of therapies and can now be found in almost every market around the world.

Sanofi SoloStar® Disposable insulin pen injector

Design planning Usability and HF Mechanical engineering Industrial design Colour, material and finish Instructional design Graphic design Prototyping Testing and evaluation Production support

Sanofi Toujeo® SoloStar® Disposable pen injector for concentrated insulin

Design planning Mechanical engineering Industrial design Colour, material and finish Instructional design Packaging design Graphic design Prototyping Testing and evaluation Production support

Toujeo® SoloStar®

Building on the multi-award winning SoloStar® platform, DCA partnered Sanofi to develop a new range of pen-injectors for Toujeo®, a triple concentrated basal insulin.

Toujeo® SoloStar® contains 450 insulin units, deliverable in single unit increments. Due to the triple-concentrated formulation, dose accuracy tolerance limits are three times tighter than for a standard pen, meaning that doses need to be delivered within a ±0.0033mL window.

Toujeo® SoloStar® was painstakingly engineered to achieve this exacting requirement and also to provide an ultra-low injection force.